Literature DB >> 17402272

Effect of Withania somnifera on forced swimming test induced immobility in mice and its interaction with various drugs.

P C Shah1, N A Trivedi, J D Bhatt, K G Hemavathi.   

Abstract

The objective of the present study was to evaluate the antidepressant action of Withania somnifera (WS) as well as its interaction with the conventional antidepressant drugs and to delineate the possible mechanism of its antidepressant action using forced swimming model in mice. Effect of different doses of WS, fluoxetine and imipramine were studied on forced swimming test induced mean immobility time (MIT). Moreover effect of WS 100 mg/kg, i.p. was observed at different time intervals. Effect produced by combination of sub therapeutic doses of WS with imipramine (2.5 mg/kg, i.p.) as well as fluoxetine (2.5 mg/kg, i.p.) were also observed. Effect of WS (100 mg/kg, i.p.) as well as combination of WS (37.5 mg/kg, i.p.) with either imipramine (2.5 mg/kg, i.p.) or fluoxetine (2.5 mg/kg, i.p.) were observed in mice pretreated with reserpine (2 mg/kg, i.p.) and clonidine (0.15 mg/kg, i.p.). Effects of prazosin (3 mg/kg, i.p.) or haloperidol (0.1 mg/kg, i.p.) pre-treatment were also observed on WS induced decrease in MIT. WS produced dose dependent decrease in MIT. Maximum effect in MIT was observed after 30 min of treatment with WS 100 mg/kg, i.p. Combination of WS (37.5 mg/kg, i.p.) with imipramine (2.5 mg/kg, i.p.) or fluoxetine (2.5 mg/kg, i.p.) also produced significant decrease in the MIT. Clonidine and reserpine induced increase in MIT, was significantly reversed by treatment with WS (100 mg/kg, i.p.) as well as combination of WS (37.5 mg/kg, i.p.) with either imipramine (2.5 mg/kg, i.p.) or fluoxetine (2.5 mg/kg, i.p.). Pre-treatment with prazosin but not haloperidol, significantly antagonized the WS (100 mg/kg, i.p.) induced decrease in MIT. It is concluded that, WS produced significant decrease in MIT in mice which could be mediated partly through a adrenoceptor as well as alteration in the level of central biogenic amines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17402272

Source DB:  PubMed          Journal:  Indian J Physiol Pharmacol        ISSN: 0019-5499


  7 in total

1.  Involvement of monoaminergic systems in anxiolytic and antidepressive activities of the standardized extract of Cocos nucifera L.

Authors:  Eliane Brito Cortez Lima; Caren Nádia Soares de Sousa; Lucas Nascimento Meneses; Yuri Freitas E Silva Pereira; Natália Castelo Branco Matos; Rayanne Brito de Freitas; Nycole Brito Cortez Lima; Manoel Cláudio Azevedo Patrocínio; Luzia Kalyne Almeida Moreira Leal; Glauce Socorro Barros Viana; Silvânia Maria Mendes Vasconcelos
Journal:  J Nat Med       Date:  2016-10-21       Impact factor: 2.343

2.  Antidepressant-like effect and toxicological parameters of extract and withanolides isolated from aerial parts of Solanum capsicoides All. (Solanaceae).

Authors:  Marcel Petreanu; Paula Maia; Janieire L da Rocha Pittarello; Lucimara C Loch; Franco Delle Monache; Alice L Perez; Godofredo Solano-Arias; Valdir Cechinel Filho; Márcia Maria de Souza; Rivaldo Niero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-04-13       Impact factor: 3.000

3.  Study protocol and rationale for a prospective, randomized, double-blind, placebo-controlled study to evaluate the effects of Ashwagandha (Withania somnifera) extract on nonrestorative sleep.

Authors:  Abhijit Deshpande; Nushafreen Irani; Rathna Balakrishnan
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

4.  Effect of Ashwagandha Withanolides on Muscle Cell Differentiation.

Authors:  Jia Wang; Huayue Zhang; Ashish Kaul; Kejuan Li; Didik Priyandoko; Sunil C Kaul; Renu Wadhwa
Journal:  Biomolecules       Date:  2021-10-04

Review 5.  Natural Withanolides in the Treatment of Chronic Diseases.

Authors:  Peter T White; Chitra Subramanian; Hashim F Motiwala; Mark S Cohen
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

6.  Considerations of Pool Dimensions in the Forced Swim Test in Predicting the Potential Antidepressant Activity of Drugs.

Authors:  Gilberto Uriel Rosas-Sánchez; León Jesús German-Ponciano; Juan Francisco Rodríguez-Landa
Journal:  Front Behav Neurosci       Date:  2022-01-07       Impact factor: 3.558

Review 7.  Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia.

Authors:  Alex B Speers; Kadine A Cabey; Amala Soumyanath; Kirsten M Wright
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.